Europe — EMA
Octaplex
Human Coagulation Factor IX, the active ingredient in Octaplex, is a coagulation factor concentrate presented as a strength/form for intravenous use.
Request sourcing
What is Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?
Human Coagulation Factor IX, the active ingredient in Octaplex, is a coagulation factor concentrate presented as a strength/form for intravenous use. It treats hemophilia B and related clotting disorders in patients requiring factor replacement therapy.
GNH USA supplies Octaplex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F used for?
Octaplex is a coagulation factor concentrate used in the intrinsic pathway of blood clotting to manage bleeding disorders. - Hemophilia B: Provides functional factor IX to reduce bleeding frequency and severity. - Acquired factor IX deficiency: Restores clotting ability during surgical procedures or trauma. - Peri‑operative management: Supports hemostasis in patients with known factor IX deficiency undergoing surgery.
What are the side effects of Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?
Adverse reactions to Octaplex are generally related to its protein nature and the intravenous route.
Common Side Effects: - Fever - Headache - Nausea - Mild infusion‑site erythema - Transient hypertension - Fatigue
Serious or Rare Side Effects: - Anaphylactic reaction - Development of inhibitors (neutralising antibodies) - Thromboembolic events - Severe hypersensitivity - Viral transmission risk (theoretical) - Renal impairment associated with large volume infusions.
What precautions apply to Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?
Octaplex should be used with careful clinical monitoring and adherence to handling guidelines. - Allergy assessment: Verify no known hypersensitivity to human plasma‑derived proteins. - Inhibitor screening: Test for pre‑existing factor IX inhibitors before initiation. - Renal function: Monitor patients with compromised kidney function during high‑volume infusions. - Concomitant anticoagulants: Adjust dosing if the patient is receiving other anticoagulant therapies. - Pregnancy and lactation: Use only if the benefit outweighs potential risk to mother and fetus. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F interact with?
Octap64?
Major Interactions ( Avoid ): t t t t
t t ullet ullet \\ ullet \\ \\ \ \n t \\